Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;82(6):883-885.
doi: 10.1136/ard-2022-223464. Epub 2023 Jan 31.

Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

Luuk Wieske #  1   2 , Eileen W Stalman #  3 , P J Koos van Dam  1 , Laura Y Kummer  1   4 , Maurice Steenhuis  4 , Zoe L E van Kempen  5 , Joep Killestein  5 , Adriaan G Volkers  6 , Sander W Tas  7 , Laura Boekel  8 , Gertjan Wolbink  4   8 , Anneke Van der Kooi  1 , Joost Raaphorst  1 , Mark Löwenberg  6 , Bart Takkenberg  6 , Geert R A M D'Haens  6 , Phyllis I Spuls  9 , Marcel W Bekkenk  10 , Annelie H Musters  10 , Nicoline F Post  10 , Angela L Bosma  10 , Marc L Hilhorst  11 , Yosta Vegting  11 , Frederique J Bemelman  11 , Alexandre Voskuyl  12 , Bo Broens  12 , Agner Parra Sanchez  6   12 , Cécile A C M van Els  13   14 , Jelle De Wit  15   16 , Abraham Rutgers  17 , Karina de Leeuw  17 , Barbara Horváth  18 , Jan J G M Verschuuren  19 , Annabel M Ruiter  19 , Lotte van Ouwerkerk  20 , Diane van der Woude  20 , Cornelia F Allaart  20 , Y K Onno Teng  21 , Pieter van Paassen  22 , Matthias H Busch  23   24 , Papay B P Jallah  24 , Esther Brusse  25 , Pieter A van Doorn  25 , Adája Elisabeth Baars  25 , Dirkjan Hijnen  26 , Corine R G Schreurs  26 , W Ludo Van der Pol  27 , H Stephan Goedee  27 , Sofie Keijzer  4 , Jim Keijser  4 , Olvi Cristianawati  4 , Anja Ten Brinke  4 , Niels J M Verstegen  4 , Koos A H Zwinderman  28 , S Marieke van Ham  4   29 , Taco W Kuijpers  4   30 , Theo Rispens  4 , Filip Eftimov  31 ; T2B! immunity against SARS-CoV-2 study group
Affiliations

Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

Luuk Wieske et al. Ann Rheum Dis. 2023 Jun.
No abstract available

Keywords: Autoimmune Diseases; Covid-19; Tumor Necrosis Factor Inhibitors; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Competing interests: FE and TWK report (governmental) grants from ZonMw to studyimmune response after SARS-Cov-2 vaccination in autoimmune diseases. FE also reports grants from Prinses Beatrix Spierfonds, CSL Behring, Kedrion, Terumo BCT, Grifols, Takeda Pharmaceutical Company, and GBS-CIDP Foundation; consulting fees from UCB Pharma and CSlBehring; and honoraria from Grifols. AJvdK reports grants from CSLBehring and participation on an advisory board for Argen-X. ML reports agrant from Galapagos not related to this study, and honoraria from BristolMyers Squibb, Pfizer, Takeda and Tillotts. PIS is involved in clinical trials with many pharmaceutical industries that manufacture drugs used for the treatment of, for example, psoriasis and atopic dermatitis, for which financial compensation is paid to the department or hospital, and is achief investigator of the TREAT NL registry taskforce and SECURE-AD registry. MWB is a secretary for the Dutch Experimental Dermatology Board; head of the pigmentary disorders group within the Dutch Dermatology Board; and reports honoraria from Pfizer, Sanofi, Novartis, and Fondation René Touraine. JK has speaking relationships with MerckSerono, Biogen Idec, TEVA, Sanofi, Genzyme, Roche and Novartis; received financial support to his institution for researchactivities from Merck Serono, Bayer Shcering Pharma, Biogen Idec, GlaxoSmithKline (GSK), Roche, Teva, Sanofi, Genzyme and Novartis. BH reports unpaid positions as a medical adviser for several patient groups, aboard position for ERN-SKIN, and associate editor for The British Journalof Dermatology; reports grants from AbbVIe, Akari Therapeutics, Celgene and Novartis; consulting fees from UCB Pharma, Novartis, and Janssen; and honoraria from AbbVie. JJGMV reports consulting fees from Argenx, Alexion and NMD Pharma, and is a coinventor on patent applicationsbased on MuSK-related research. DJH reportsgrants from AbbVie, AstraZeneca, Janssen, LEO Pharma and UCB; honoraria from AbbVie, Galderma, Janssen, Lilly, Pfizer, Sanofi, and UCB; and a paid position on an advisory board for BIOMAP IMI. PAvD participated on an advisory board for Octapharma. PvP reports grantsfrom Alexion Pharma and GSK, and participation on advisory boards for GSK and Vifor Pharma. GRAMD’H reports consulting fees from AbbVie, Agomab, AstraZeneca, AM Pharma, AMT, Arena Pharmaceuticals, BristolMyers Squibb, Boehringer Ingelheim, Celltrion, Eli Lilly, ExeliomBiosciences, Exo Biologics, Galapagos, Index Pharmaceuticals, Kaleido, Roche, Gilead, GSK, Gossamerbio, Pfizer, Immunic, Johnson and Johnson, Origo, Polpharma, Procise Diagnostics, Prometheus Laboratories, Prometheus Biosciences, Progenity and Protagonist; honoraria from AbbVie, Arena, Galapagos, Gilead, Pfizer, Bristol MyersSquibb and Takeda; and participation on advisory boards for AbbVie, Seres Health, Galapagos, and AstraZeneca. RBT reports honoraria fromSobi and Norgine, and participation on an advisory board for Norgine. SHG is a board member of the Dutch Society of Clinical Neurophysiology (unpaid), reports grants from Prinses Beatrix Spierfonds, and receivedspeaker fees from Shire/Takeda. KAHZ reports paid data safetymonitoring board positions for Torrent and Foresee.

Similar articles

See all similar articles

Cited by

Publication types

Substances